Joe Kubulak

Joe Kubulak serves as Chief Operating Officer at Specialty Rx, Inc. Specialty Rx, Inc operates in the pharmaceuticals sector with approximately 480.0 employees. Specialty Rx, Inc generates annual revenue of 2000000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,469 c suite-level executives.

Gmail Outlook Google Apps Microsoft Office 365 Autotask Amazon AWS Facebook Custom Audiences Mobile Friendly Google Analytics Nginx Google Tag Manager reCAPTCHA Bootstrap Framework Apache WordPress.org JQuery 2.1.1 Linkedin Marketing Solutions Ubuntu Facebook Login (Connect) Google Font API Facebook Widget Remote

pharmaceutical manufacturing drug care healthcare facilities compliance model nationwide pharmacy quality care pharmacy services patient care medication management healthcare logistics specialty pharmacy regulations adherence diversity in healthcare staff recruitment competitive benefits healthcare solutions seamless service facility management healthcare partnerships community collaboration telepharmacy drug distribution patient support health policy compliance prescription fulfillment pharmaceutical care essential healthcare services pharmacy integration care coordination healthcare innovation patient-focused care clinical services healthcare access pharmaceutical regulations insurance support pharmacy technology quality assurance service excellence florida pharmacy new jersey healthcare nursing facility support healthcare compliance healthcare workforce medicare services managed care pharmacy recruitment job opportunities careers in healthcare healthcare management pharmaceuticals medical

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Joe Kubulak in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Specialty Rx, Inc.

Joe Kubulak's Position in the MessageCEO Database

• •Joe Kubulak is 1 of 1 verified executive contact we track at Specialty Rx, Inc.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •8 verified contacts work at pharmaceuticals companies in the 480.0 employee range (same size as Specialty Rx, Inc).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Joe Kubulak directly?

Joe Kubulak's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Operating Officer at Specialty Rx, Inc. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Joe Kubulak work for?

Joe Kubulak is Chief Operating Officer at Specialty Rx, Inc, a company in the pharmaceuticals sector with 480.0 employees.

Can I pitch or sell to Joe Kubulak?

As Chief Operating Officer at Specialty Rx, Inc, Joe Kubulak is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Joe Kubulak directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Joe Kubulak in?

Joe Kubulak works in the pharmaceuticals industry as Chief Operating Officer at Specialty Rx, Inc. MessageCEO provides verified contact information for executives across all major industries.

Is Joe Kubulak's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Joe Kubulak's profile is kept up-to-date with the latest available information.

Last updated: June 23, 2026